The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

Tonix Pharmaceuticals (TNXP) announced it has been awarded a grant from the Medical CBRN Defense Consortium, MCDC, to support the development of TNX-801. MCDC is a consortium of industrial ...

Biopharmaceutical company Vivasun Pharmaceutical is strong in early trading on the 5th. The increased buying interest is interpreted as news that their domestic No. 38 new drug, Anafraju, a non ...

Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total ...

The Amphastar Pharmaceuticals' logo and other trademarks or service marks of Amphastar Pharmaceuticals, Inc., including, but not limited to Primatene MIST®, Amphadase®, Cortrosyn®, REXTOVY ...

March 5 (Reuters) - Merck's (MRK.N), opens new tab injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics (HALO.O ...

The news moves fast, but understanding takes time. At Vox, we don’t chase every headline. We focus on what really matters. We break down the biggest stories — and the ones others overlook ...